Cancer vaccines target relapse prevention

Cancer vaccines under development primarily aim to prevent relapses in patients who have already been diagnosed, especially those with melanoma. These vaccines are designed to strengthen the immune system's ability to detect and destroy residual or recurring cancer cells after treatment.

Preventive vaccines reduce cancer risk

There are existing vaccines that prevent infections linked to certain cancers. For example, the HPV vaccine helps reduce the risk of cancers caused by human papillomavirus, and it is recommended for both girls and boys in France.

Therapeutic vaccines focus on individual patients

Therapeutic vaccines differ from preventive ones in that they are not meant for the general population. Instead, they are tailored to individuals who have already been diagnosed with cancer, aiming to enhance their immune response to specific cancer cells rather than prevent the disease altogether.

Vaccine meaning differs from childhood immunizations

The term "vaccine" in the context of cancer treatment can be misleading. Unlike childhood vaccines that offer broad protection, cancer vaccines are more accurately described as treatment strategies aimed at reducing the likelihood of cancer recurrence in specific patients.

Melanoma treatment shows progress

The most advanced progress in cancer vaccine research is seen in melanoma treatment. After surgical removal of the tumor, these vaccines are used to help the immune system recognize and attack any remaining cancer cells, potentially preventing the disease from returning.